Use of 13-HODE as a regulator of vascular biocompatibility...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S560000, C514S552000, C514S558000, C514S458000, C514S474000

Reexamination Certificate

active

09833257

ABSTRACT:
This invention relates to the regulation of vascular endothelium biocompatibility and to the inhibition of vessel wall cell and other types of cell hyperplasia following vessel wall dysfunction and/or injury. More particularly, the invention relates to the dietetic and pharmaceutical preparations of 13-hydroxyoctadeca-9Z, 11E-dienoic acid (13-HODE) and its use in reducing or inhibiting vessel wall hyperlasia and restoring vessel wall biocompatibility.

REFERENCES:
patent: 4526902 (1985-07-01), Rubin
patent: 4871768 (1989-10-01), Bistrian et al.
patent: 5015483 (1991-05-01), Haynes et al.
patent: 5023100 (1991-06-01), Chang et al.
patent: 5043328 (1991-08-01), Weithmann
patent: 5102912 (1992-04-01), Streber
patent: 5141958 (1992-08-01), Crozier-Willi et al.
patent: 5223285 (1993-06-01), DeMichele et al.
patent: 5434183 (1995-07-01), Larsson-Backstrom
patent: 5502077 (1996-03-01), Breivik et al.
patent: 5567730 (1996-10-01), Miyashita et al.
patent: 6077525 (2000-06-01), Vanderhoek
patent: 6160141 (2000-12-01), Seidel
patent: 6710032 (2004-03-01), Teter et al.
patent: 0209066 (1987-01-01), None
patent: 0955047 (1999-11-01), None
patent: 60237017 (1985-11-01), None
patent: 62164622 (1987-07-01), None
patent: 7291862 (1995-07-01), None
patent: WO99/18956 (1999-04-01), None
patent: WO99/44585 (1999-09-01), None
patent: WO99/59562 (1999-11-01), None
patent: WO00/55318 (2000-09-01), None
patent: WO01/03688 (2001-01-01), None
Miller et al., “Induction of Epidermal Hyperproliferation by Topical n-3 Polyunsaturated Fatty Acids on Guinea Pig Skin Linked to Decreased Levels of 13-Hydorxyoctadecadienoic Acid (13-Hode)”, J Invest Dermatol, 1990, 94:353-358.
Cho et al., “Incorporation of 13-hydroxyoctadecadienoic Fatty acid (13-Hode) into epidermal ceramides and phospholipids: phosphlipase C-catalyzed release of novel 13-HoDE-containing diacylglycerol”, J Lipid Res, 1994, 35(2):255-62.
Truitt et al, Biochimca et Biophysica Acta 1438, 1999, pp. 239-246, Antiplatelet effects of conjugated linoleic acid isomers.
Tloti et al, Thrombosis Research 62, 1991, pp. 305-317, Effect of 13-Hydroxyoctadeca-9, 11-Dienoic Acid (13-Hode) on . . . .
Buchanan et al, Wien Klin Wochenschr, 105/11, 1993, pp. 309-313 Prevention and treatment of thrombosis: Novel strategies . . . .
Bertomeu et al, Thrombosis Research 59, 1990, pp. 819-830, Selective Effects of Dietary Fats on Vascular 13-Hode . . . .
Brister et al, Recent Adv. in Prost . . . Research, 1998, pp. 275-278, Effects of Linoleic Acid and/or Marine Fish Oil . . . .
Buchanan et al, Recent Adv. in Prost . . . Research, 1998, pp. 265-269, Effects of 13-Hode and Other Momohydroxides on Integrin . . . .
Buchanan et al, in Adv. Exp. Med Biol 469, 1998, pp. 463-469, Linoleic Acid Metabolities in Health and Disease.
Buchanan et al, Wien Klin Wochenschr 111/3, 1999, pp. 81-89, A rationale for targeting antithrombotic therapy at the . . . .
Haas et al, Adv in Prost . . . Research, vol. 21, pp. 667-670, 13-Hode Synethesis in Internal Mammary Arteries and . . . .
Buchanan et al, Canadian Jour of Cardiology, vol. 16, Sep. 2000, p. 150F, 13-Hode Prevents Vascular Hyperplasia and . . . .

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Use of 13-HODE as a regulator of vascular biocompatibility... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of 13-HODE as a regulator of vascular biocompatibility..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of 13-HODE as a regulator of vascular biocompatibility... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3782486

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.